Ivana Galetić

645 total citations
10 papers, 494 citations indexed

About

Ivana Galetić is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ivana Galetić has authored 10 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ivana Galetić's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Enzyme function and inhibition (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ivana Galetić is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Enzyme function and inhibition (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Ivana Galetić collaborates with scholars based in Switzerland, United States and Australia. Ivana Galetić's co-authors include Brian A. Hemmings, Sauveur-Michel Maira, Evan Ingley, Marcus Thelen, Derek P. Brazil, Stefanie Kaech, Mirjana Andjelković, Daniela Brodbeck, Roger Meier and Jongsun Park and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ivana Galetić

10 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivana Galetić Switzerland 7 315 107 82 64 52 10 494
Natalie Goldberger United States 7 296 0.9× 116 1.1× 78 1.0× 67 1.0× 41 0.8× 10 462
Shuliang Zhao China 13 293 0.9× 112 1.0× 18 0.2× 88 1.4× 22 0.4× 21 469
W. Kang South Korea 9 178 0.6× 292 2.7× 79 1.0× 148 2.3× 132 2.5× 24 492
Suguru Hayase Japan 16 282 0.9× 109 1.0× 18 0.2× 193 3.0× 98 1.9× 34 511
Helen Ye United States 5 209 0.7× 95 0.9× 11 0.1× 73 1.1× 24 0.5× 7 346
Ranjana Tavorath United States 8 285 0.9× 82 0.8× 7 0.1× 166 2.6× 112 2.2× 11 562
Hirofumi Akashi Japan 11 329 1.0× 50 0.5× 13 0.2× 140 2.2× 50 1.0× 17 573
Dae Hwa Choi South Korea 10 257 0.8× 43 0.4× 7 0.1× 84 1.3× 24 0.5× 13 368
A. Nigel Brooks United Kingdom 4 387 1.2× 76 0.7× 9 0.1× 66 1.0× 33 0.6× 5 468
Norihiro Nakada Japan 12 272 0.9× 38 0.4× 12 0.1× 130 2.0× 55 1.1× 20 407

Countries citing papers authored by Ivana Galetić

Since Specialization
Citations

This map shows the geographic impact of Ivana Galetić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Galetić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Galetić more than expected).

Fields of papers citing papers by Ivana Galetić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Galetić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Galetić. The network helps show where Ivana Galetić may publish in the future.

Co-authorship network of co-authors of Ivana Galetić

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Galetić. A scholar is included among the top collaborators of Ivana Galetić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Galetić. Ivana Galetić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hofman, Michael S., Ben Tran, Darren R. Feldman, et al.. (2024). First-in-human safety, imaging and dosimetry of [68Ga]Ga-DPI-4452, a novel CA IX-targeting peptide, in patients with clear cell renal cell carcinoma.. Journal of Clinical Oncology. 42(4_suppl). 373–373. 1 indexed citations
2.
Hofman, Michael S., Ben Tran, Darren R. Feldman, et al.. (2024). First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma. Journal of Nuclear Medicine. 65(5). 740–743. 32 indexed citations
3.
Feldman, Darren R., Ben Tran, Louise Emmett, et al.. (2023). First-in-human clinical trial design of a first-in-class theranostic approach with a peptide-based radioligand targeting CA IX-expressing tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS3160–TPS3160. 2 indexed citations
4.
Reichardt, Peter, Jean‐Yves Blay, Hans Gelderblom, et al.. (2012). Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib. Annals of Oncology. 23(7). 1680–1687. 97 indexed citations
5.
Yin, Ophelia, Marc S. Rudoltz, Ivana Galetić, et al.. (2011). Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(11). 1580–1586. 9 indexed citations
6.
Galetić, Ivana, Sauveur-Michel Maira, Mirjana Andjelković, & Brian A. Hemmings. (2003). Negative Regulation of ERK and Elk by Protein Kinase B Modulates c-fos Transcription. Journal of Biological Chemistry. 278(7). 4416–4423. 35 indexed citations
7.
Maira, Sauveur-Michel, Ivana Galetić, Derek P. Brazil, et al.. (2001). Carboxyl-Terminal Modulator Protein (CTMP), a Negative Regulator of PKB/Akt and v-Akt at the Plasma Membrane. Science. 294(5541). 374–380. 207 indexed citations
8.
Slade, Neda, Ivana Galetić, Sanja Kapitanović, & Krešimir Pavelić. (2001). The efficacy of retroviral herpes simplex virus thymidine kinase gene transfer and ganciclovir treatment on the inhibition of melanoma growth in vitro and in vivo. Archives of Dermatological Research. 293(10). 484–490. 4 indexed citations
9.
10.
Galetić, Ivana, Mirjana Andjelković, Roger Meier, et al.. (1999). Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer. Pharmacology & Therapeutics. 82(2-3). 409–425. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie Goldberger Breakdown of academic impact, for papers by Shuliang Zhao Breakdown of academic impact, for papers by W. Kang Breakdown of academic impact, for papers by Suguru Hayase Breakdown of academic impact, for papers by Helen Ye Breakdown of academic impact, for papers by Ranjana Tavorath Breakdown of academic impact, for papers by Hirofumi Akashi Breakdown of academic impact, for papers by Dae Hwa Choi Breakdown of academic impact, for papers by A. Nigel Brooks Breakdown of academic impact, for papers by Norihiro Nakada
Rankless by CCL
2026